Cathepsin B and I and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck

Neoplasma

Volumn 48, Issue 1, 2001, Pages 66-71

  Strojan, P ^a   Budihna, M ^a   Smid L ^a   Svetic, B ^a   Vrhovec, I ^a   Skrk J ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Cathepsins; Head and neck carcinoma; Prognosis; Stefins; Tumor marker

Indexed keywords

CATHEPSIN B; CATHEPSIN L; STEFIN A; STEFIN B; TUMOR MARKER; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE C; CSTA PROTEIN, HUMAN; CYSTATIN; CYSTATIN B; PPGB PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; PROGNOSIS; RELAPSE; SQUAMOUS CELL CARCINOMA; BLOOD; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SURVIVAL; TUMOR RECURRENCE;

ADULT; AGED; CARBOXYPEPTIDASE C; CARBOXYPEPTIDASES; CARCINOMA, SQUAMOUS CELL; CATHEPSIN B; CYSTATINS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034745651     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Serum proteinase activities in head and neck squamous cell carcinoma patients
2. Prognostic value of total cathepsin B in invasive ductal carcinoma of the breast
3. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma
4. Serum cathepsin B levels and urinary excretion of cathepsin B in the cancer patients with remote metastasis
5. Nonparametric estimation from incomplete observation
6. Endo- and aminopeptidase activities of rat cathepsin H
7. Lysosomal proteinases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer
8. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients
9. Cysteine proteinases and their endogenous inhibitors: Target proteins for prognosis, diagnosis and therapy in cancer
10. Prognostic value of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer
11. Cysteine proteinase inhibitors stefin A, stefin B and cystatin C in sera from patients with colorectal cancer: Relation to prognosis
12. Serum cathepsin B-like activity as a potential marker of laryngeal carcinoma
13. Biochemical studies in head and neck cancer
14. Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: Potential clinical implication
15. Cathepsin B in predicting the extent of the cervix carcinoma
16. Increased cathepsin L levels in serum in some patients with ovarian cancer: Comparison with CA125 and CA72-4
17. Tumour markers in clinical oncology
18. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
19. Cysteine proteinase inhibitors in serum of patients with head and neck tumors
20. Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck
21. Cathepsin H in squamous cell carcinoma of the head and neck
22. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck
23. Cathepsin D, B and L circulating levels as prognostic markers of malignant progression
24. Cathepsin B-like activity as a serum tumour marker in ovarian carcinoma